ArticleTobacco use insights2025
Smokeless Tobacco Usage and Oral Cancer Risk: A Hospital-Based Case-Control Study From Bangladesh.
Article in Tobacco use insights, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of Dental Status and Smokeless Tobacco (SLT) Using Behavior Among Bangladeshi Dental Patients: A Structural Equation Modeling (SEM) Analysis.Substance use : research and treatmentArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Smokeless tobacco (SLT) use is common in South Asia and strongly associated with oral cancer. In Bangladesh, where SLT use is widespread, evidence remains limited. This study examined the association between SLT use and oral cancer among Bangladeshi adults and estimated the population-level burden. Methods: This first hospital-based case-control study from Bangladesh examined the association between SLT use and oral cancer. Conducted in Dhaka between July and December 2015. A total of 169 newly diagnosed oral cancer cases and 338 frequency-matched controls were recruited. Structured interviews collected data on SLT use, smoking, alcohol, BMI, and socio-demographic variables. Adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. Population attributable fractions (PAFs) were calculated based on national SLT prevalence. Results: SLT use was strongly associated with oral cancer (adjusted OR: 8.78; 95% CI: 5.14-15.00). Risk was higher in women (OR: 14.33, 95% CI: 6.33-32.42) than in men (OR: 5.29, 95% CI: 2.62-10.67). Male dual users of SLT and smoked tobacco had the greatest risk (OR: 17.23, 95% CI: 5.70-52.01). Analysis by SLT type indicated significant independent associations with oral cancer for both Betel Quid (BQ) usage with tobacco (OR: 8.93, 95% CI: 5.23-15.27) and without tobacco (OR: 4.43, 95% CI: 1.94-10.10). A dose-response relationship was observed, particularly in women. SLT use accounted for an estimated 41% of male and 76% of female oral cancer cases in Bangladesh. Conclusion: SLT is a major, modifiable risk factor for oral cancer in Bangladesh, particularly among women and dual tobacco users. These findings support the need for stronger regulation, gender-sensitive education, and targeted SLT control strategies. Local evidence such as this is vital to shaping national and international oral cancer prevention policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.